Bamlanivimab plus etesevimab for the treatment of COVID-19 in high-risk ambulatory patients including those with diabetes
Year: 2021
Type: article
Source: Diabetologia
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3203030649
